STS/ACC TVT Registry Mitral Module
Part of paid clinical trials in Washington D.C., District of Columbia.
- Sponsor
- American College of Cardiology
- Study ID
- NCT02245763
- Status
- Recruiting
Conditions
- Mitral Valve Regurgitation
Eligibility Criteria
- Sex
- ALL
- Age
- 1 Year - N/A
- Healthy Volunteers
- Accepted
Interventions
- Leaflet Clip — DEVICE
Study Details
The TVT Registry™ is a benchmarking tool developed to track patient safety and real-world outcomes related to the transcatheter mitral valve repair (TMVR) procedure. Created by The Society of Thoracic Surgeons (STS) and the American College of Cardiology (ACC), the TVT Registry is designed to monitor the safety and efficacy of this new procedure for the treatment of mitral valve disease.
Key Dates
- Start date
- Nov 30, 2013
- Status verified
- Apr 2024
- Primary completion
- Dec 31, 2030
- Completion
- Dec 31, 2030
Study Design
- Enrollment
- 4,000 participants (estimated)
Primary Outcome Measure
Number of Patients with Adverse Events [ Time Frame: 30 days ]
Central Contacts
- Joan K Michaels, RN202-375-6309
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| American College of Cardiology | Washington D.C. | District of Columbia | 20037 | - |
Find similar trials in Washington D.C., DC
By research site
Related Studies
- Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.Recruiting · Medtronic Cardiovascular · Birmingham, Alabama
- Percutaneous or Surgical Repair In Mitral Prolapse And Regurgitation for ≥60 Year-olds (PRIMARY)Recruiting · Annetine Gelijns · Los Angeles, California
- AltaValve Pivotal TrialRecruiting · 4C Medical Technologies, Inc. · Phoenix, Arizona